# Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

> **NCT04426643** · PHASE1,PHASE2 · COMPLETED · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 10 (actual)

## Conditions studied

- Urinary Incontinence

## Interventions

- **BIOLOGICAL:** Autologous adipose-derived mesenchymal stem cells
- **OTHER:** Standard treatment according to the Clinical protocols

## Key facts

- **NCT ID:** NCT04426643
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2021-02-20
- **Final completion:** 2021-03-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04426643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04426643, "Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04426643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*